Stereotaxis, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Stereotaxis, Inc. on December 18, 2014, reporting significant regulatory milestones achieved on that date. The Company is a medical technology firm based in St. Louis, Missouri.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory events rather than financial performance.
Material Changes and Regulatory Events
- US FDA Clearance: Received 510(k) clearance from the U.S. Food and Drug Administration to market the Vdrive with V-CAS Catheter Advancement System.
- Japan Approval: Received regulatory approval for the Odyssey system from the Japan Pharmaceuticals and Medical Devices Agency.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies beyond the announcement of the regulatory approvals.
Investor Verification Checklist
- Confirm the commercial launch timeline for the Vdrive with V-CAS system in the U.S. market.
- Verify the commercial availability and reimbursement status of the Odyssey system in Japan.
- Review subsequent quarterly reports to assess the financial impact of these new market approvals.